Traitement de tla sclérose en plaques: nouveautés et complications [New treatment options in multiple sclerosis and their complications].

Détails

ID Serval
serval:BIB_8385AEC5E86A
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
Traitement de tla sclérose en plaques: nouveautés et complications [New treatment options in multiple sclerosis and their complications].
Périodique
Revue Médicale Suisse
Auteur(s)
Schluep M., Lalive P.H., Du Pasquier R.A.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
2013
Volume
9
Numéro
384
Pages
940-943
Langue
français
Notes
Publication types: English Abstract ; Journal Article Publication Status: ppublish
Résumé
A new therapeutic era opened for multiple sclerosis (MS) with the appearance of molecules given p.o. and/or molecules with greater efficiency. Early diagnosis is critical, as the time and the choice of therapeutic intervention. The initiation of treatments must be personalized, including the risks associated with MS and those potentially related to the treatment chosen, answering the question <Who, when and how to treat?>. Monitoring tools that allow to objectively evaluate: I) MS activity and aggressiveness for each patient and 2) the safety of treatments and their risks of complications, must be further investigated.
Mots-clé
Drug Therapy/adverse effects, Humans, Multiple Sclerosis/drug therapy
Pubmed
Création de la notice
19/08/2013 17:16
Dernière modification de la notice
03/03/2018 18:52
Données d'usage